Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Dabigatran 💬
(Dabigatran (USAN/INN))		1件: Dabigatran (Dabigatran)1件: Dabigatran1件: F2 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬3件: 85, 91, 124 💬
2 Dabigatran etexilate 💬
(Dabigatran etexilate (USAN/INN))		1件: Dabigatran etexilate (Dabigatran etexilate mesilate)1件: Dabigatran etexilate1件: F2 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬2件: 51, 75 💬
3 Dabigatran etexilate mesylate 💬
(Dabigatran etexilate mesylate (USAN), Dabigatran etexilate methanesulfonate (JAN), Dabigatran etexilate mesilate, DABIGATRAN, DABIGATRAN ETEXILATE)		1件: Dabigatran etexilate (Dabigatran etexilate mesilate)1件: Dabigatran etexilate1件: F2 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬2件: 51, 75 💬